← Back to Search

DEMA-Pro for Mild Cognitive Impairment

N/A
Waitlist Available
Led By Yvonne Lu, PhD, RN
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week before dema-pro intervention and post-dema-pro program within 10 days
Awards & highlights

Study Summary

This study is evaluating whether a set of activities can improve sleep habits in people with dementia.

Eligible Conditions
  • Mild Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week before dema-pro intervention and post-dema-pro program within 10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week before dema-pro intervention and post-dema-pro program within 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Function
Secondary outcome measures
Depression
Hospitalization Rate
Number, Types of ER Visits
+2 more
Other outcome measures
Staff Experiences of DEMA-Pro training and delivery

Trial Design

1Treatment groups
Experimental Treatment
Group I: DEMA-ProExperimental Treatment1 Intervention
The DEMA-Pro intervention will be administrated. Subjects will attend six weekly, 1-hour telephone sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
the DEMA-Pro intervention
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,111 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,667 Previous Clinical Trials
28,004,845 Total Patients Enrolled
Yvonne Lu, PhD, RNPrincipal InvestigatorIndiana University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home
Yvonne Lu 2021. "DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04796415.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top